首页 | 本学科首页   官方微博 | 高级检索  
     

西妥昔单抗联合FOLFOX4方案在转移性结直肠癌一线治疗的疗效预测
引用本文:马冬,董秋美. 西妥昔单抗联合FOLFOX4方案在转移性结直肠癌一线治疗的疗效预测[J]. 循证医学, 2009, 9(3): 152-154. DOI: 10.3969/j.issn.1671-5144.2009.03.018
作者姓名:马冬  董秋美
作者单位:广东省人民医院肿瘤中心、广东省医学科学院,广州,510080
摘    要:1 文献来源 Bokemeyer C, Bondarenko I, Makhon A, et al. Fluorouracil, Leucovorin, and Oxaliplatin with and without Cetuximab in the first-line treatment of metastatic colorectal cancer [J]. J Clin Oncol,2009,27(5):663-671.

关 键 词:结直肠肿瘤  西妥昔单抗  FOLFOX4  KRAS

Prediction for Cetuximab Combination with FOLFOX4 Regimen in the First-Line Treatment of Metastatic Colorectal Cancer
MA Dong,DONG Qiu-mei. Prediction for Cetuximab Combination with FOLFOX4 Regimen in the First-Line Treatment of Metastatic Colorectal Cancer[J]. The Journal of Evidence-Based Medicine, 2009, 9(3): 152-154. DOI: 10.3969/j.issn.1671-5144.2009.03.018
Authors:MA Dong  DONG Qiu-mei
Affiliation:MA Dong, DONG Qiu-mei (Cancer Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China)
Abstract:1 文献来源 Bokemeyer C, Bondarenko I, Makhon A, et al. Fluorouracil, Leucovorin, and Oxaliplatin with and without Cetuximab in the first-line treatment of metastatic colorectal cancer [J]. J Clin Oncol, 2009,27(5):663-671.
Keywords:FOLFOX4  KRAS
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《循证医学》浏览原始摘要信息
点击此处可从《循证医学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号